GenSight Biologics S.A. (LON: 0RIM)
London
· Delayed Price · Currency is GBP · Price in EUR 0.275
-0.016 (-5.66%)
At close: Jan 20, 2025
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of 28.76 million as of January 23, 2025. Its market cap has increased by 33.26% in one year.
Market Cap
28.76M
Enterprise Value
42.07M
Revenue
1.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 212.26M to 28.76M, a decrease of -86.45%. That is a compound annual growth rate of -20.88%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| Shell | 167.06B |
| HSBC Holdings | 145.16B |
| Unilever | 114.25B |
| Rio Tinto Group | 85.64B |
| RELX PLC | 74.08B |
| BP p.l.c. | 67.25B |
| British American Tobacco p.l.c. | 65.03B |